Loading...
Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
Janumet(TM,) a fixed dose combination of sitagliptin/metformin HCL manufactured by Merck Pharmaceuticals, has received US Food and Drug Administration approval for treatment of patients with type 2 diabetes, that are inadequately controlled, either by sitagliptin or metformin alone or together in fr...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048013/ https://ncbi.nlm.nih.gov/pubmed/21437126 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|